Synthesis and Hypoglycemic and Anti-inflammatory Activity Screening of Novel Substituted 5-[Morpholino(Phenyl)Methyl]-Thiazolidine-2,4-Diones and Their Molecular Docking Studies

• Published in: Turkish journal of pharmaceutical sciences Vol. 16; no. 4; pp. 380 - 391
• Main Authors: Karumanchi, Srikanth Kumar, Atmakuri, Lakshmana Rao, Mandava, V Basaveswara Rao, Rajala, Srikala
• Format: Journal Article
• Language: English
• Published: Turkey Türk Eczacılar Birliği 01.12.2019; Galenos Publishing
• Subjects: Eczacılık; Original; Sağlık Hizmetleri; Tıp; Ankara; Türkiye; docking studies; in vivo hypoglycemic activity; Thiazolidinediones bearing morpholine; Mannich reaction; in vitro anti-inflammatory activity; mannich reaksiyonu; doking çalışmaları; in vivo hipoglisemik aktivite; in vitro antienflamatuvar aktivite; Morfolin taşıyan tiyazolidinonlar
• ISSN: 1304-530X; 2148-6247
• DOI: 10.4274/tjps.galenos.2018.82612

The aim was the synthesis of novel substituted 5-[morpholino(phenyl)methyl]-thiazolidine-2,4-diones and screening for their hypoglycemic activity and anti-inflammatory activity, as well as molecular docking studies to find out active potential lead molecules. Substituted aromatic aldehydes, thiazolidine-2,4-dione, and morpholine on Mannich reaction gave the title compounds. They were characterized by physical and spectral methods. hypoglycemic activity was examined in alloxan induced Wistar albino rats by tail tipping method. anti-inflammatory activity was tested by human red blood cell (HRBC) membrane stabilization and protein denaturation. Using AutoDock, molecular docking studies were carried out to find out the best fit ligands. Series of substituted 5-[morpholino(phenyl)methyl]-thiazolidine-2,4-diones were synthesized and chemically they were confirmed by spectral techniques. Acute toxic studies of hypoglycemic activity results revealed that compounds 4c, 4h, and 4n exhibited good activity at 35 mg/kg body weight. Chronic toxic study results indicated that compounds 4h and 4n exhibited good activity at 70 mg/kg body weight. Anti-inflammatory activity results indicated the highest inhibition was shown by compounds 4k and 4f at 500 μg/mL in HRBC membrane stabilization. In protein denaturation, the highest inhibition was shown by compound 4k at 500 μg/mL. In molecular docking studies, compounds 4h and 4n exhibited higher binding affinity at PPARγ receptor protein and compound 4k exhibited higher binding affinity at COX-1 and COX-2 actives sites. Microwave irradiation produced high yield in short reaction times. The presence of electron releasing groups at the para position of the phenyl ring may give the ability to produce hypoglycemic activity and the presence of electron withdrawing groups at the para position of the phenyl ring causes anti-inflammatory activity. The results showed that some compounds exhibited good hypoglycemic and anti-inflammatory activities. Compounds 4h and 4n exhibited higher binding affinity at PPARγ receptor protein and compound 4k exhibited higher binding affinity at COX isoenzymes' active sites in molecular docking studies.